Rising demand for biologics and generic medicines is predicted to primarily drive the contract pharmaceutical manufacturing market size over the forecast time frame. Owing to complex manufacturing requirements and capital-intensive nature of the business, various industry players identified higher profits in developing alliances with CMO i.e. Contract Manufacturing Outsourcing for both commercial and clinical stage production. This will further boost the industry growth from 2022 to 2027.
In addition, shifting trend of the pharmaceutical industry players toward core competency areas will further add volume to the industry size. Increasing requirement for production technologies together with state-of-the-art processes will prove to be highly effective for meeting regulatory needs. However, prohibited logistics expenses may hinder the contract pharmaceutical market size during the study period.
Global contract pharmaceutical manufacturing market is segregated on the basis of product as, Active Pharmaceutical Ingredient Manufacturing, Finished Dosage Formulation Development & Manufacturing, Secondary Packaging Application. Finished Dosage Formulation Development & Manufacturing is further bifurcated into Solid Dose Formulation, Liquid Dose Formulation, and Injectable Dose Formulation.
Global contract pharmaceutical manufacturing market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The contract pharmaceutical manufacturing market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Catalent Inc., Recipharm AB, Jubilant Life Sciences Ltd, Patheon Inc., Boehringer Ingelheim, Pfizer Centresource, Aenova, Famar, Baxter Biopharma Solutions, and Lonza are among the major players in the global contract pharmaceutical manufacturing market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Contract Pharmaceutical Manufacturing Market has been segmented as below:
Contract Pharmaceutical Manufacturing Market, By Service
Contract Pharmaceutical Manufacturing Market, By Region
The report covers:
Report scope:
Global contract pharmaceutical manufacturing market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global contract pharmaceutical manufacturing market share. Major industry players with significant revenue share include Catalent Inc., Recipharm AB, Jubilant Life Sciences Ltd, Patheon Inc., Boehringer Ingelheim, Pfizer Centresource, Aenova, Famar, Baxter Biopharma Solutions, and Lonza.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Medical non-woven disposable market
Cholesterol Screening/ Cholesterol Lab Testing Services Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Increasing outsourcing volume by big pharmaceutical industry players
4.2.2. Increasing R&D investment
4.3. Restraints
4.3.1. Stringent regulatory requirements
4.3.2. Increasing lead time and logistics costs
4.4. Opportunities
4.4.1. Expansion in the service offering of CMOS
4.4.2. Advent of CDMO Model
4.5. Challenges
4.5.1. Capacity utilization issues affecting the profitability of CMOS
5. Contract Pharmaceutical Manufacturing Market, By Service
5.1. Key Points
5.2. Active Pharmaceutical Ingredient (API) Manufacturing
5.3. Finished Dosage Formulation (FDF) Development & Manufacturing
5.3.1. Solid Dose Formulation
5.3.2. Liquid Dose Formulation
5.3.3. Injectable Dose Formulation
5.4. Secondary Packaging Application
6. Competitive Landscape
6.1. Introduction
6.2. Recent Developments
6.2.1. Mergers & Acquisitions
6.2.2. New Product Developments
6.2.3. Portfolio/Production Capacity Expansions
6.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
6.2.5. Others
7. Company Profile
7.1. Catalent Inc.
7.1.1. Company Overview
7.1.2. Product/Service Landscape
7.1.3. Financial Overview
7.1.4. Recent Developments
7.2. Recipharm AB
7.2.1. Company Overview
7.2.2. Product/Service Landscape
7.2.3. Financial Overview
7.2.4. Recent Developments
7.3. Jubilant Life Sciences Ltd
7.3.1. Company Overview
7.3.2. Product/Service Landscape
7.3.3. Financial Overview
7.3.4. Recent Developments
7.4. Patheon Inc.
7.4.1. Company Overview
7.4.2. Product/Service Landscape
7.4.3. Financial Overview
7.4.4. Recent Developments
7.5. Boehringer Ingelheim
7.5.1. Company Overview
7.5.2. Product/Service Landscape
7.5.3. Financial Overview
7.5.4. Recent Developments
7.6. Pfizer Centresource
7.6.1. Company Overview
7.6.2. Product/Service Landscape
7.6.3. Financial Overview
7.6.4. Recent Developments
7.7. Aenova
7.7.1. Company Overview
7.7.2. Product/Service Landscape
7.7.3. Financial Overview
7.7.4. Recent Developments
7.8. Famar
7.8.1. Company Overview
7.8.2. Product/Service Landscape
7.8.3. Financial Overview
7.8.4. Recent Developments
7.9. Baxter Biopharma Solutions
7.9.1. Company Overview
7.9.2. Product/Service Landscape
7.9.3. Financial Overview
7.9.4. Recent Developments
7.10. Lonza
7.10.1. Company Overview
7.10.2. Product/Service Landscape
7.10.3. Financial Overview
7.10.4. Recent Developments
The Contract Pharmaceutical Manufacturing Market has been segmented as below:
Contract Pharmaceutical Manufacturing Market, By Service
Contract Pharmaceutical Manufacturing Market, By Region
